scholarly journals Presence of maternal antibodies to human immunodeficiency virus 1 envelope glycoprotein gp120 epitopes correlates with the uninfected status of children born to seropositive mothers.

1989 ◽  
Vol 86 (20) ◽  
pp. 8055-8058 ◽  
Author(s):  
P. Rossi ◽  
V. Moschese ◽  
P. A. Broliden ◽  
C. Fundaro ◽  
I. Quinti ◽  
...  
1997 ◽  
Vol 41 (7) ◽  
pp. 1521-1530 ◽  
Author(s):  
M R Boyd ◽  
K R Gustafson ◽  
J B McMahon ◽  
R H Shoemaker ◽  
B R O'Keefe ◽  
...  

We have isolated and sequenced a novel 11-kDa virucidal protein, named cyanovirin-N (CV-N), from cultures of the cyanobacterium (blue-green alga) Nostoc ellipsosporum. We also have produced CV-N recombinantly by expression of a corresponding DNA sequence in Escherichia coli. Low nanomolar concentrations of either natural or recombinant CV-N irreversibly inactivate diverse laboratory strains and primary isolates of human immunodeficiency virus (HIV) type 1 as well as strains of HIV type 2 and simian immunodeficiency virus. In addition, CV-N aborts cell-to-cell fusion and transmission of HIV-1 infection. Continuous, 2-day exposures of uninfected CEM-SS cells or peripheral blood lymphocytes to high concentrations (e.g., 9,000 nM) of CV-N were not lethal to these representative host cell types. The antiviral activity of CV-N is due, at least in part, to unique, high-affinity interactions of CV-N with the viral surface envelope glycoprotein gp120. The biological activity of CV-N is highly resistant to physicochemical denaturation, further enhancing its potential as an anti-HIV microbicide.


Sign in / Sign up

Export Citation Format

Share Document